Clinical Trial Update: Pharmacokinetics, Pharmacodynamics, and Safety of Alogliptin in Children, Adolescents and Adults With Type 2 Diabetes Mellitus [Phase 1]

View source ↗

Summary

Phase 1 study evaluating the pharmacokinetics, pharmacodynamics, and safety of alogliptin in children, adolescents, and adults with Type 2 diabetes mellitus; re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Alogliptin (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Diabetes Mellitus, Type 2 | Phase 1 | Status: COMPLETED | Results posted: 2015-01-29